# Latigo Biotherapeutics Inc. (LTGO)

Source: https://www.quantisnow.com/company/LTGO
Generated: 2026-11-17T02:49:12.168Z

- Ticker: LTGO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0002056611

## About

Latigo Biotherapeutics is a private clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction, with the goal to provide effective, rapid-acting pain relief. Latigo is supported by leading investors, including Westlake Village BioPartners, Foresite Capital, 5AM Ventures, and Blue Owl Capital. Latigo's lead program is LTG-001, an oral, selective Nav1.8 inhibitor in development to treat acute pain.

## Latest LTGO news and filings

- 2026-11-13 21:31 UTC [SEC Schedule 13G] [SEC Form SCHEDULE 13G filed by Latigo Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-latigo-biotherapeutics-inc-6791001)
- 2026-11-06 22:18 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Latigo Biotherapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-latigo-biotherapeutics-inc-6779555)
- 2026-11-05 12:23 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Latigo Biotherapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-latigo-biotherapeutics-inc-6774632)
- 2026-11-05 12:05 UTC [SEC Form 8-K] [Latigo Biotherapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/latigo-biotherapeutics-inc-filed-sec-form-8-k-results-of-operations-6774563)
- 2026-11-05 11:47 UTC [Earnings] [Latigo Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights](https://www.quantisnow.com/insight/latigo-biotherapeutics-reports-third-quarter-2026-financial-results-and-recent-6774305)
- 2026-11-05 11:45 UTC [Leadership Update] [Latigo Biotherapeutics Announces CEO Transition to Support the Company’s Next Phase of Growth](https://www.quantisnow.com/insight/latigo-biotherapeutics-announces-ceo-transition-to-support-the-companys-next-6774268)
- 2026-11-03 21:05 UTC [Conference Announcement] [Latigo Biotherapeutics to Participate in Upcoming Investor Conferences in November](https://www.quantisnow.com/insight/latigo-biotherapeutics-to-participate-in-upcoming-investor-conferences-in-november-6769452)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LTGO
- Earnings history: https://www.quantisnow.com/earnings/LTGO
- Dividend history: https://www.quantisnow.com/dividends/LTGO
- Insider transactions: https://www.quantisnow.com/insiders/LTGO
- Options chain: https://www.quantisnow.com/options/LTGO
- SEC 8-K filings only: https://www.quantisnow.com/company/LTGO/8-k
- RSS and alerts for LTGO: https://www.quantisnow.com/docs/rss-feeds.md
